BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharmaconomics//FDA Catalyst Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
BEGIN:VEVENT
UID:pharmaconomics-453@pharmaconomics
DTSTAMP:20260707T034520Z
DTSTART;VALUE=DATE:20261231
DTEND;VALUE=DATE:20270101
SUMMARY:IRON PDUFA — bitopertin (estimated date)
DESCRIPTION:The FDA's approval decision on bitopertin for erythropoietic protoporphyria (EPP) is due ~ Dec 31\, 2026. A green light opens the market\; a complete response letter (CRL) usually sinks the stock.\n\nPrimary source: https://www.sec.gov/Archives/edgar/data/1816736/000119312526009871/iron-ex99_2.htm\n\nTrack it: https://www.pharmaconomics.com/e/453
URL:https://www.pharmaconomics.com/e/453
TRANSP:TRANSPARENT
BEGIN:VALARM
TRIGGER:-P1D
ACTION:DISPLAY
DESCRIPTION:IRON catalyst tomorrow
END:VALARM
END:VEVENT
END:VCALENDAR